Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 95

1.

Exploring Australian Hajj Tour Operators' Knowledge and Practices Regarding Pilgrims' Health Risks: A Qualitative Study.

Alqahtani AS, Tashani M, Heywood AE, Booy R, Rashid H, Wiley KE.

JMIR Public Health Surveill. 2019 May 23;5(2):e10960. doi: 10.2196/10960.

2.

PhD thesis opposing immunisation: Failure of academic rigour with real-world consequences.

Wiley KE, Leask J, Burgess MA, McIntyre PB.

Vaccine. 2019 Mar 14;37(12):1541-1545. doi: 10.1016/j.vaccine.2018.12.024. No abstract available.

3.

Hand hygiene compliance and effectiveness against respiratory infections among Hajj pilgrims: a systematic review.

Alqahtani AS, Fakeerh M, Bondagji D, Park S, Heywood AE, Wiley KE, Booy R, Rashid H.

Infect Disord Drug Targets. 2018 Oct 1. doi: 10.2174/1871526518666181001145041. [Epub ahead of print]

PMID:
30277169
4.

Australian caregivers' perceptions of influenza vaccination in pregnancy: A mixed methods exploration.

King CL, Chow MY, Leask J, Wiley KE.

Women Birth. 2019 Jun;32(3):240-245. doi: 10.1016/j.wombi.2018.07.010. Epub 2018 Aug 8.

PMID:
30098979
5.

Germline mutations in PPFIBP2 are associated with lethal prostate cancer.

Wu Y, Yu H, Zheng SL, Feng B, Kapron AL, Na R, Boyle JL, Shah S, Shi Z, Ewing CM, Wiley KE, Luo J, Walsh PC, Carter HB, Helfand BT, Cooney KA, Xu J, Isaacs WB.

Prostate. 2018 Dec;78(16):1222-1228. doi: 10.1002/pros.23697. Epub 2018 Jul 24.

PMID:
30043417
6.

Midwives' attitudes, beliefs and concerns about childhood vaccination: A review of the global literature.

Attwell K, Wiley KE, Waddington C, Leask J, Snelling T.

Vaccine. 2018 Oct 22;36(44):6531-6539. doi: 10.1016/j.vaccine.2018.02.028. Epub 2018 Feb 23. Review.

PMID:
29483029
7.

Much ado about flu: A mixed methods study of parental perceptions, trust and information seeking in a pandemic.

King CL, Chow MYK, Wiley KE, Leask J.

Influenza Other Respir Viruses. 2018 Jul;12(4):514-521. doi: 10.1111/irv.12547. Epub 2018 Mar 13.

8.

An audit of the quality of online immunisation information available to Australian parents.

Wiley KE, Steffens M, Berry N, Leask J.

BMC Public Health. 2017 Jan 13;17(1):76. doi: 10.1186/s12889-016-3933-9.

9.

Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death.

Na R, Zheng SL, Han M, Yu H, Jiang D, Shah S, Ewing CM, Zhang L, Novakovic K, Petkewicz J, Gulukota K, Helseth DL Jr, Quinn M, Humphries E, Wiley KE, Isaacs SD, Wu Y, Liu X, Zhang N, Wang CH, Khandekar J, Hulick PJ, Shevrin DH, Cooney KA, Shen Z, Partin AW, Carter HB, Carducci MA, Eisenberger MA, Denmeade SR, McGuire M, Walsh PC, Helfand BT, Brendler CB, Ding Q, Xu J, Isaacs WB.

Eur Urol. 2017 May;71(5):740-747. doi: 10.1016/j.eururo.2016.11.033. Epub 2016 Dec 15.

10.

Australian Hajj pilgrims' perception about mass casualty incidents versus emerging infections at Hajj.

Alqahtani AS, Yamazaki K, Alqahtani WH, Tashani M, Heywood AE, Booy R, Wiley KE, Rashid H.

Travel Med Infect Dis. 2017 Jan - Feb;15:81-83. doi: 10.1016/j.tmaid.2016.11.002. Epub 2016 Nov 14. No abstract available.

PMID:
27856351
11.

Association between Australian Hajj Pilgrims' awareness of MERS-CoV, and their compliance with preventive measures and exposure to camels.

Alqahtani AS, Wiley KE, Mushta SM, Yamazaki K, BinDhim NF, Heywood AE, Booy R, Rashid H.

J Travel Med. 2016 Jul 18;23(5). doi: 10.1093/jtm/taw046. Print 2016 May.

PMID:
27432904
12.

Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21.

Teerlink CC, Leongamornlert D, Dadaev T, Thomas A, Farnham J, Stephenson RA, Riska S, McDonnell SK, Schaid DJ, Catalona WJ, Zheng SL, Cooney KA, Ray AM, Zuhlke KA, Lange EM, Giles GG, Southey MC, Fitzgerald LM, Rinckleb A, Luedeke M, Maier C, Stanford JL, Ostrander EA, Kaikkonen EM, Sipeky C, Tammela T, Schleutker J, Wiley KE, Isaacs SD, Walsh PC, Isaacs WB, Xu J, Cancel-Tassin G, Cussenot O, Mandal D, Laurie C, Laurie C; PRACTICAL consortium; International Consortium for Prostate Cancer Genetics, Thibodeau SN, Eeles RA, Kote-Jarai Z, Cannon-Albright L.

Hum Genet. 2016 Aug;135(8):923-38. doi: 10.1007/s00439-016-1690-6. Epub 2016 Jun 4.

13.

Exploring barriers to and facilitators of preventive measures against infectious diseases among Australian Hajj pilgrims: cross-sectional studies before and after Hajj.

Alqahtani AS, Wiley KE, Tashani M, Willaby HW, Heywood AE, BinDhim NF, Booy R, Rashid H.

Int J Infect Dis. 2016 Jun;47:53-9. doi: 10.1016/j.ijid.2016.02.005. Epub 2016 Feb 10.

14.

Camel exposure and knowledge about MERS-CoV among Australian Hajj pilgrims in 2014.

Alqahtani AS, Wiley KE, Tashani M, Heywood AE, Willaby HW, BinDhim NF, Booy R, Rashid H.

Virol Sin. 2016 Feb;31(1):89-93. doi: 10.1007/s12250-015-3669-1. No abstract available.

PMID:
26810660
15.

Pilot use of a novel smartphone application to track traveller health behaviour and collect infectious disease data during a mass gathering: Hajj pilgrimage 2014.

Alqahtani AS, BinDhim NF, Tashani M, Willaby HW, Wiley KE, Heywood AE, Booy R, Rashid H.

J Epidemiol Glob Health. 2016 Sep;6(3):147-55. doi: 10.1016/j.jegh.2015.07.005. Epub 2015 Aug 13.

16.

Australian Hajj pilgrims' knowledge, attitude and perception about Ebola, November 2014 to February 2015.

Alqahtani AS, Wiley KE, Willaby HW, BinDhim NF, Tashani M, Heywood AE, Booy R, Rashid H.

Euro Surveill. 2015 Mar 26;20(12). pii: 21072.

17.

Understanding pregnant women's attitudes and behavior toward influenza and pertussis vaccination.

Wiley KE, Cooper SC, Wood N, Leask J.

Qual Health Res. 2015 Mar;25(3):360-70. doi: 10.1177/1049732314551061. Epub 2014 Sep 22.

PMID:
25246330
18.

Respiratory vaccine uptake during pregnancy.

Wiley KE, Leask J.

Lancet Respir Med. 2013 Mar;1(1):9-11. doi: 10.1016/S2213-2600(13)70024-9. Epub 2013 Mar 4. No abstract available.

PMID:
24321792
19.

Telomere length as a risk factor for hereditary prostate cancer.

Hurwitz LM, Heaphy CM, Joshu CE, Isaacs WB, Konishi Y, De Marzo AM, Isaacs SD, Wiley KE, Platz EA, Meeker AK.

Prostate. 2014 Apr;74(4):359-64. doi: 10.1002/pros.22755. Epub 2013 Nov 28.

20.

Association analysis of 9,560 prostate cancer cases from the International Consortium of Prostate Cancer Genetics confirms the role of reported prostate cancer associated SNPs for familial disease.

Teerlink CC, Thibodeau SN, McDonnell SK, Schaid DJ, Rinckleb A, Maier C, Vogel W, Cancel-Tassin G, Egrot C, Cussenot O, Foulkes WD, Giles GG, Hopper JL, Severi G, Eeles R, Easton D, Kote-Jarai Z, Guy M, Cooney KA, Ray AM, Zuhlke KA, Lange EM, Fitzgerald LM, Stanford JL, Ostrander EA, Wiley KE, Isaacs SD, Walsh PC, Isaacs WB, Wahlfors T, Tammela T, Schleutker J, Wiklund F, Grönberg H, Emanuelsson M, Carpten J, Bailey-Wilson J, Whittemore AS, Oakley-Girvan I, Hsieh CL, Catalona WJ, Zheng SL, Jin G, Lu L, Xu J; International Consortium for Prostate Cancer Genetics, Camp NJ, Cannon-Albright LA.

Hum Genet. 2014 Mar;133(3):347-56. doi: 10.1007/s00439-013-1384-2. Epub 2013 Oct 26.

21.

Pregnant women's intention to take up a post-partum pertussis vaccine, and their willingness to take up the vaccine while pregnant: a cross sectional survey.

Wiley KE, Massey PD, Cooper SC, Wood N, Quinn HE, Leask J.

Vaccine. 2013 Aug 20;31(37):3972-8. doi: 10.1016/j.vaccine.2013.06.015. Epub 2013 Jun 15.

PMID:
23777954
22.

Uptake of influenza vaccine by pregnant women: a cross-sectional survey.

Wiley KE, Massey PD, Cooper SC, Wood NJ, Ho J, Quinn HE, Leask J.

Med J Aust. 2013 Apr 15;198(7):373-5.

PMID:
23581957
23.

Sources of pertussis infection in young infants: a review of key evidence informing targeting of the cocoon strategy.

Wiley KE, Zuo Y, Macartney KK, McIntyre PB.

Vaccine. 2013 Jan 11;31(4):618-25. doi: 10.1016/j.vaccine.2012.11.052. Epub 2012 Nov 29. Review.

PMID:
23200883
24.

HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG).

Xu J, Lange EM, Lu L, Zheng SL, Wang Z, Thibodeau SN, Cannon-Albright LA, Teerlink CC, Camp NJ, Johnson AM, Zuhlke KA, Stanford JL, Ostrander EA, Wiley KE, Isaacs SD, Walsh PC, Maier C, Luedeke M, Vogel W, Schleutker J, Wahlfors T, Tammela T, Schaid D, McDonnell SK, DeRycke MS, Cancel-Tassin G, Cussenot O, Wiklund F, Grönberg H, Eeles R, Easton D, Kote-Jarai Z, Whittemore AS, Hsieh CL, Giles GG, Hopper JL, Severi G, Catalona WJ, Mandal D, Ledet E, Foulkes WD, Hamel N, Mahle L, Moller P, Powell I, Bailey-Wilson JE, Carpten JD, Seminara D, Cooney KA, Isaacs WB; International Consortium for Prostate Cancer Genetics.

Hum Genet. 2013 Jan;132(1):5-14. doi: 10.1007/s00439-012-1229-4. Epub 2012 Oct 12.

25.

Analysis of Xq27-28 linkage in the international consortium for prostate cancer genetics (ICPCG) families.

Bailey-Wilson JE, Childs EJ, Cropp CD, Schaid DJ, Xu J, Camp NJ, Cannon-Albright LA, Farnham JM, George A, Powell I, Carpten JD, Giles GG, Hopper JL, Severi G, English DR, Foulkes WD, Mæhle L, Møller P, Eeles R, Easton D, Guy M, Edwards S, Badzioch MD, Whittemore AS, Oakley-Girvan I, Hsieh CL, Dimitrov L, Stanford JL, Karyadi DM, Deutsch K, McIntosh L, Ostrander EA, Wiley KE, Isaacs SD, Walsh PC, Thibodeau SN, McDonnell SK, Hebbring S, Lange EM, Cooney KA, Tammela TL, Schleutker J, Maier C, Bochum S, Hoegel J, Grönberg H, Wiklund F, Emanuelsson M, Cancel-Tassin G, Valeri A, Cussenot O, Isaacs WB; International Consortium for Prostate Cancer Genetics.

BMC Med Genet. 2012 Jun 19;13:46. doi: 10.1186/1471-2350-13-46.

26.

Germline mutations in HOXB13 and prostate-cancer risk.

Ewing CM, Ray AM, Lange EM, Zuhlke KA, Robbins CM, Tembe WD, Wiley KE, Isaacs SD, Johng D, Wang Y, Bizon C, Yan G, Gielzak M, Partin AW, Shanmugam V, Izatt T, Sinari S, Craig DW, Zheng SL, Walsh PC, Montie JE, Xu J, Carpten JD, Isaacs WB, Cooney KA.

N Engl J Med. 2012 Jan 12;366(2):141-9. doi: 10.1056/NEJMoa1110000.

27.

Validation of prostate cancer risk-related loci identified from genome-wide association studies using family-based association analysis: evidence from the International Consortium for Prostate Cancer Genetics (ICPCG).

Jin G, Lu L, Cooney KA, Ray AM, Zuhlke KA, Lange EM, Cannon-Albright LA, Camp NJ, Teerlink CC, Fitzgerald LM, Stanford JL, Wiley KE, Isaacs SD, Walsh PC, Foulkes WD, Giles GG, Hopper JL, Severi G, Eeles R, Easton D, Kote-Jarai Z, Guy M, Rinckleb A, Maier C, Vogel W, Cancel-Tassin G, Egrot C, Cussenot O, Thibodeau SN, McDonnell SK, Schaid DJ, Wiklund F, Grönberg H, Emanuelsson M, Whittemore AS, Oakley-Girvan I, Hsieh CL, Wahlfors T, Tammela T, Schleutker J, Catalona WJ, Zheng SL, Ostrander EA, Isaacs WB, Xu J; International Consortium for Prostate Cancer Genetics.

Hum Genet. 2012 Jul;131(7):1095-103. doi: 10.1007/s00439-011-1136-0. Epub 2011 Dec 25.

28.

Human polymorphisms at long non-coding RNAs (lncRNAs) and association with prostate cancer risk.

Jin G, Sun J, Isaacs SD, Wiley KE, Kim ST, Chu LW, Zhang Z, Zhao H, Zheng SL, Isaacs WB, Xu J.

Carcinogenesis. 2011 Nov;32(11):1655-9. doi: 10.1093/carcin/bgr187. Epub 2011 Aug 19.

29.

Chromosomes 4 and 8 implicated in a genome wide SNP linkage scan of 762 prostate cancer families collected by the ICPCG.

Lu L, Cancel-Tassin G, Valeri A, Cussenot O, Lange EM, Cooney KA, Farnham JM, Camp NJ, Cannon-Albright LA, Tammela TL, Schleutker J, Hoegel J, Herkommer K, Maier C, Vogel W, Wiklund F, Emanuelsson M, Grönberg H, Wiley KE, Isaacs SD, Walsh PC, Helfand BT, Kan D, Catalona WJ, Stanford JL, FitzGerald LM, Johanneson B, Deutsch K, McIntosh L, Ostrander EA, Thibodeau SN, McDonnell SK, Hebbring S, Schaid DJ, Whittemore AS, Oakley-Girvan I, Hsieh CL, Powell I, Bailey-Wilson JE, Cropp CD, Simpson C, Carpten JD, Seminara D, Zheng SL, Xu J, Giles GG, Severi G, Hopper JL, English DR, Foulkes WD, Maehle L, Moller P, Badzioch MD, Edwards S, Guy M, Eeles R, Easton D, Isaacs WB; International Consortium for Prostate Cancer Genetics.

Prostate. 2012 Mar;72(4):410-26. doi: 10.1002/pros.21443. Epub 2011 Jul 11.

30.

Large-scale fine mapping of the HNF1B locus and prostate cancer risk.

Berndt SI, Sampson J, Yeager M, Jacobs KB, Wang Z, Hutchinson A, Chung C, Orr N, Wacholder S, Chatterjee N, Yu K, Kraft P, Feigelson HS, Thun MJ, Diver WR, Albanes D, Virtamo J, Weinstein S, Schumacher FR, Cancel-Tassin G, Cussenot O, Valeri A, Andriole GL, Crawford ED, Haiman C, Henderson B, Kolonel L, Le Marchand L, Siddiq A, Riboli E, Travis RC, Kaaks R, Isaacs W, Isaacs S, Wiley KE, Gronberg H, Wiklund F, Stattin P, Xu J, Zheng SL, Sun J, Vatten LJ, Hveem K, Njølstad I, Gerhard DS, Tucker M, Hayes RB, Hoover RN, Fraumeni JF Jr, Hunter DJ, Thomas G, Chanock SJ.

Hum Mol Genet. 2011 Aug 15;20(16):3322-9. doi: 10.1093/hmg/ddr213. Epub 2011 May 16.

31.

Genome-wide linkage analysis of 1,233 prostate cancer pedigrees from the International Consortium for Prostate Cancer Genetics using novel sumLINK and sumLOD analyses.

Christensen GB, Baffoe-Bonnie AB, George A, Powell I, Bailey-Wilson JE, Carpten JD, Giles GG, Hopper JL, Severi G, English DR, Foulkes WD, Maehle L, Moller P, Eeles R, Easton D, Badzioch MD, Whittemore AS, Oakley-Girvan I, Hsieh CL, Dimitrov L, Xu J, Stanford JL, Johanneson B, Deutsch K, McIntosh L, Ostrander EA, Wiley KE, Isaacs SD, Walsh PC, Isaacs WB, Thibodeau SN, McDonnell SK, Hebbring S, Schaid DJ, Lange EM, Cooney KA, Tammela TL, Schleutker J, Paiss T, Maier C, Grönberg H, Wiklund F, Emanuelsson M, Farnham JM, Cannon-Albright LA, Camp NJ; International Consortium for Prostate Cancer Genetics.

Prostate. 2010 May 15;70(7):735-44. doi: 10.1002/pros.21106.

32.

Inherited genetic variant predisposes to aggressive but not indolent prostate cancer.

Xu J, Zheng SL, Isaacs SD, Wiley KE, Wiklund F, Sun J, Kader AK, Li G, Purcell LD, Kim ST, Hsu FC, Stattin P, Hugosson J, Adolfsson J, Walsh PC, Trent JM, Duggan D, Carpten J, Grönberg H, Isaacs WB.

Proc Natl Acad Sci U S A. 2010 Feb 2;107(5):2136-40. doi: 10.1073/pnas.0914061107. Epub 2010 Jan 11.

33.

Identification of a new prostate cancer susceptibility locus on chromosome 8q24.

Yeager M, Chatterjee N, Ciampa J, Jacobs KB, Gonzalez-Bosquet J, Hayes RB, Kraft P, Wacholder S, Orr N, Berndt S, Yu K, Hutchinson A, Wang Z, Amundadottir L, Feigelson HS, Thun MJ, Diver WR, Albanes D, Virtamo J, Weinstein S, Schumacher FR, Cancel-Tassin G, Cussenot O, Valeri A, Andriole GL, Crawford ED, Haiman CA, Henderson B, Kolonel L, Le Marchand L, Siddiq A, Riboli E, Key TJ, Kaaks R, Isaacs W, Isaacs S, Wiley KE, Gronberg H, Wiklund F, Stattin P, Xu J, Zheng SL, Sun J, Vatten LJ, Hveem K, Kumle M, Tucker M, Gerhard DS, Hoover RN, Fraumeni JF Jr, Hunter DJ, Thomas G, Chanock SJ.

Nat Genet. 2009 Oct;41(10):1055-7. doi: 10.1038/ng.444. Epub 2009 Sep 20.

34.

Fine-mapping and family-based association analyses of prostate cancer risk variants at Xp11.

Lu L, Sun J, Isaacs SD, Wiley KE, Smith S, Pruett K, Zhu Y, Zhang Z, Wiklund F, Grönberg H, Walsh PC, Chang BL, Zheng SL, Isaacs WB, Xu J.

Cancer Epidemiol Biomarkers Prev. 2009 Jul;18(7):2132-6. doi: 10.1158/1055-9965.EPI-08-1221. Epub 2009 Jun 23.

35.

Prostate cancer risk associated loci in African Americans.

Xu J, Kibel AS, Hu JJ, Turner AR, Pruett K, Zheng SL, Sun J, Isaacs SD, Wiley KE, Kim ST, Hsu FC, Wu W, Torti FM, Walsh PC, Chang BL, Isaacs WB.

Cancer Epidemiol Biomarkers Prev. 2009 Jul;18(7):2145-9. doi: 10.1158/1055-9965.EPI-09-0091. Epub 2009 Jun 23.

36.

Two independent prostate cancer risk-associated Loci at 11q13.

Zheng SL, Stevens VL, Wiklund F, Isaacs SD, Sun J, Smith S, Pruett K, Wiley KE, Kim ST, Zhu Y, Zhang Z, Hsu FC, Turner AR, Johansson JE, Liu W, Kim JW, Chang BL, Duggan D, Carpten J, Rodriguez C, Isaacs W, Grönberg H, Xu J.

Cancer Epidemiol Biomarkers Prev. 2009 Jun;18(6):1815-20. doi: 10.1158/1055-9965.EPI-08-0983.

37.

Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patients.

Kader AK, Sun J, Isaacs SD, Wiley KE, Yan G, Kim ST, Fedor H, DeMarzo AM, Epstein JI, Walsh PC, Partin AW, Trock B, Zheng SL, Xu J, Isaacs W.

Prostate. 2009 Aug 1;69(11):1195-205. doi: 10.1002/pros.20970.

38.

A novel prostate cancer susceptibility locus at 19q13.

Hsu FC, Sun J, Wiklund F, Isaacs SD, Wiley KE, Purcell LD, Gao Z, Stattin P, Zhu Y, Kim ST, Zhang Z, Liu W, Chang BL, Walsh PC, Duggan D, Carpten JD, Isaacs WB, Grönberg H, Xu J, Zheng SL.

Cancer Res. 2009 Apr 1;69(7):2720-3. doi: 10.1158/0008-5472.CAN-08-3347. Epub 2009 Mar 24.

39.

Fine mapping association study and functional analysis implicate a SNP in MSMB at 10q11 as a causal variant for prostate cancer risk.

Chang BL, Cramer SD, Wiklund F, Isaacs SD, Stevens VL, Sun J, Smith S, Pruett K, Romero LM, Wiley KE, Kim ST, Zhu Y, Zhang Z, Hsu FC, Turner AR, Adolfsson J, Liu W, Kim JW, Duggan D, Carpten J, Zheng SL, Rodriguez C, Isaacs WB, Grönberg H, Xu J.

Hum Mol Genet. 2009 Apr 1;18(7):1368-75. doi: 10.1093/hmg/ddp035. Epub 2009 Jan 19.

40.

Sequence variants at 22q13 are associated with prostate cancer risk.

Sun J, Zheng SL, Wiklund F, Isaacs SD, Li G, Wiley KE, Kim ST, Zhu Y, Zhang Z, Hsu FC, Turner AR, Stattin P, Liu W, Kim JW, Duggan D, Carpten J, Isaacs W, Grönberg H, Xu J, Chang BL.

Cancer Res. 2009 Jan 1;69(1):10-5. doi: 10.1158/0008-5472.CAN-08-3464.

41.

Association of prostate cancer risk variants with clinicopathologic characteristics of the disease.

Xu J, Isaacs SD, Sun J, Li G, Wiley KE, Zhu Y, Hsu FC, Wiklund F, Turner AR, Adams TS, Liu W, Trock BJ, Partin AW, Chang B, Walsh PC, Grönberg H, Isaacs W, Zheng S.

Clin Cancer Res. 2008 Sep 15;14(18):5819-24. doi: 10.1158/1078-0432.CCR-08-0934.

42.

Evidence for two independent prostate cancer risk-associated loci in the HNF1B gene at 17q12.

Sun J, Zheng SL, Wiklund F, Isaacs SD, Purcell LD, Gao Z, Hsu FC, Kim ST, Liu W, Zhu Y, Stattin P, Adami HO, Wiley KE, Dimitrov L, Sun J, Li T, Turner AR, Adams TS, Adolfsson J, Johansson JE, Lowey J, Trock BJ, Partin AW, Walsh PC, Trent JM, Duggan D, Carpten J, Chang BL, Grönberg H, Isaacs WB, Xu J.

Nat Genet. 2008 Oct;40(10):1153-5. doi: 10.1038/ng.214. Epub 2008 Aug 31.

43.

Identification of a putative intracellular allosteric antagonist binding-site in the CXC chemokine receptors 1 and 2.

Nicholls DJ, Tomkinson NP, Wiley KE, Brammall A, Bowers L, Grahames C, Gaw A, Meghani P, Shelton P, Wright TJ, Mallinder PR.

Mol Pharmacol. 2008 Nov;74(5):1193-202. doi: 10.1124/mol.107.044610. Epub 2008 Aug 1.

PMID:
18676678
44.

Cumulative effect of five genetic variants on prostate cancer risk in multiple study populations.

Sun J, Chang BL, Isaacs SD, Wiley KE, Wiklund F, Stattin P, Duggan D, Carpten JD, Trock BJ, Partin AW, Walsh PC, Grönberg H, Xu J, Isaacs WB, Zheng SL.

Prostate. 2008 Sep 1;68(12):1257-62. doi: 10.1002/pros.20793.

45.

Association between sequence variants at 17q12 and 17q24.3 and prostate cancer risk in European and African Americans.

Sun J, Purcell L, Gao Z, Isaacs SD, Wiley KE, Hsu FC, Liu W, Duggan D, Carpten JD, Grönberg H, Xu J, Chang BL, Partin AW, Walsh PC, Isaacs WB, Zheng SL.

Prostate. 2008 May 15;68(7):691-7. doi: 10.1002/pros.20754.

46.

Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer.

Gudmundsson J, Sulem P, Rafnar T, Bergthorsson JT, Manolescu A, Gudbjartsson D, Agnarsson BA, Sigurdsson A, Benediktsdottir KR, Blondal T, Jakobsdottir M, Stacey SN, Kostic J, Kristinsson KT, Birgisdottir B, Ghosh S, Magnusdottir DN, Thorlacius S, Thorleifsson G, Zheng SL, Sun J, Chang BL, Elmore JB, Breyer JP, McReynolds KM, Bradley KM, Yaspan BL, Wiklund F, Stattin P, Lindström S, Adami HO, McDonnell SK, Schaid DJ, Cunningham JM, Wang L, Cerhan JR, St Sauver JL, Isaacs SD, Wiley KE, Partin AW, Walsh PC, Polo S, Ruiz-Echarri M, Navarrete S, Fuertes F, Saez B, Godino J, Weijerman PC, Swinkels DW, Aben KK, Witjes JA, Suarez BK, Helfand BT, Frigge ML, Kristjansson K, Ober C, Jonsson E, Einarsson GV, Xu J, Gronberg H, Smith JR, Thibodeau SN, Isaacs WB, Catalona WJ, Mayordomo JI, Kiemeney LA, Barkardottir RB, Gulcher JR, Thorsteinsdottir U, Kong A, Stefansson K.

Nat Genet. 2008 Mar;40(3):281-3. doi: 10.1038/ng.89. Epub 2008 Feb 10.

47.

Chromosome 8q24 risk variants in hereditary and non-hereditary prostate cancer patients.

Sun J, Lange EM, Isaacs SD, Liu W, Wiley KE, Lange L, Gronberg H, Duggan D, Carpten JD, Walsh PC, Xu J, Chang BL, Isaacs WB, Zheng SL.

Prostate. 2008 Apr 1;68(5):489-97. doi: 10.1002/pros.20695.

PMID:
18213635
48.

Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP.

Duggan D, Zheng SL, Knowlton M, Benitez D, Dimitrov L, Wiklund F, Robbins C, Isaacs SD, Cheng Y, Li G, Sun J, Chang BL, Marovich L, Wiley KE, Bälter K, Stattin P, Adami HO, Gielzak M, Yan G, Sauvageot J, Liu W, Kim JW, Bleecker ER, Meyers DA, Trock BJ, Partin AW, Walsh PC, Isaacs WB, Grönberg H, Xu J, Carpten JD.

J Natl Cancer Inst. 2007 Dec 19;99(24):1836-44. Epub 2007 Dec 11.

PMID:
18073375
49.
50.

Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans.

Zheng SL, Sun J, Cheng Y, Li G, Hsu FC, Zhu Y, Chang BL, Liu W, Kim JW, Turner AR, Gielzak M, Yan G, Isaacs SD, Wiley KE, Sauvageot J, Chen HS, Gurganus R, Mangold LA, Trock BJ, Gronberg H, Duggan D, Carpten JD, Partin AW, Walsh PC, Xu J, Isaacs WB.

J Natl Cancer Inst. 2007 Oct 17;99(20):1525-33. Epub 2007 Oct 9.

PMID:
17925536

Supplemental Content

Loading ...
Support Center